Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00223860 · ClinicalTrials.gov registry record · NA

Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.

A NA study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT00223860: Completed NA study, sponsored by US Department of Veterans Affairs.

NCT00223860 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00223860, a NA study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

There is evidence that has shown that serum testosterone levels are low in persons with chronic spinal cord injury (SCI). The question arises as to whether the defect in testosterone production is from the hypothalamic pituitary system (part of the brain that plays a role in testosterone release) or from the male testes. Studies to date are inconclusive. This study, will examine if persons with SCI has a normal hormonal regulation of the male hormone testosterone in comparison to persons who are able-bodied. This will help understand the physical and metabolic changes that occur in persons with SCI.

Interventions

  • DRUG Human chorionic gonadotropin (hCG)
  • DRUG Luteinizing hormone releasing hormone (LHRH)

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2001-07
Est. Completion 2007-12
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00223860 record still lists

NCT00223860 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Human chorionic gonadotropin (hCG) is the first listed.

NCT00223860 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00223860 about?

NCT00223860 is a clinical study titled "Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.". There is evidence that has shown that serum testosterone levels are low in persons with chronic spinal cord injury (SCI). The question arises as to whether the defect in testosterone production is from the hypothalamic pituitary system (part of the brain that plays a role in testosterone release) or...

What is the current status of trial NCT00223860?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2001-07. Estimated completion is 2007-12.

What interventions are being tested in trial NCT00223860?

The interventions under investigation include: Human chorionic gonadotropin (hCG) (DRUG), Luteinizing hormone releasing hormone (LHRH) (DRUG).

Who is sponsoring clinical trial NCT00223860?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00223860's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00223860, the US trial registry maintained by the National Library of Medicine. NCT00223860 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.